Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany

Published:2014-05-10 Issue:11 Volume:23 Page:1192-1204
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Prestel Jürgen¹,Volkers Peter²,Mentzer Dirk¹,Lehmann Helmar C.³⁴,Hartung Hans‐Peter³,Keller‐Stanislawski Brigitte¹,

Affiliation:

1. Division of Safety of Medicinal Products and Medical Devices Paul‐Ehrlich‐Institut, Federal Institute for Vaccines and Biomedicines Langen Germany

2. Division of EU Co‐operation/Microbiology Paul‐Ehrlich‐Institut, Federal Institute for Vaccines and Biomedicines Langen Germany

3. Department of Neurology Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

4. Department of Neurology University Hospital of Cologne Cologne Germany

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3638

Reference44 articles.

1. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

2. The Epidemiology of Guillain-Barré Syndrome Worldwide

3. Incidence of Guillain-Barré syndrome in Germany

4. Guillain–Barré Syndrome

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between vaccination and the risk of central demyelination: results from a case-referent study;Journal of Neurology;2023-06-23

2. Real-world data on the incidence and risk of Guillain–Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study;Scientific Reports;2023-03-07

3. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis;Frontiers in Immunology;2022-12-09

4. Vaccine Technologies, Approaches Against COVID-19, Clinical Phases;essentials;2022-12-03

5. Miller-Fisher syndrome and Guillain–Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review;Human Vaccines & Immunotherapeutics;2022-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3